Fernando Andreu

Fermando Andreu (B. 1964) is CEO of 2curex AB and 2curex A/S since 2021. Fernando brings to the company more than 30 years of experience in the In Vitro Diagnostics industry, having held top management positions at companies like Chiron, Roche Diagnostics, and Sysmex, always with a focus on Global Business Development. Most recent positions include CEO at Sysmex Inostics (affiliate of Sysmex developing Liquid Biopsy technologies and products in oncology), Senior Executive Officer at Sysmex EMEA, COO of

Indivumed Group (must-omics database and Al platform for cancer discovery) and CEO of Indivumed Inc (US affiliate of Indivurned).

He holds a Degree in Business Administration and an MBA from ESADE Business School (Barcelona) where he has also been a Professor, associated with the Business Strategy department.